Hwaseong-si, Gyeonggi-do, South Korea

Su Mi Lee

This inventor holds 1 USPTO granted patent. Top assignees: Hanmi Fine Chemical Co., Ltd., Hanmi Pharm. Co., Ltd.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Su Mi Lee. Retrieved from https://idiyas.com/inventor/su-mi-lee-6vr6ea9h

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Su Mi Lee

Introduction

Su Mi Lee is an accomplished inventor based in Hwaseong-si, Gyeonggi-do, South Korea. She has made significant contributions to the field of biochemistry, particularly through her innovative work on polyethylene glycol derivatives.

Latest Patents

Su Mi Lee holds a patent for a groundbreaking invention titled "Polyethylene Glycol Derivative, Composition Comprising Same, and Method for Preparing Bioactive Polypeptide Conjugate by Using Same." This patent showcases her expertise in developing bioactive compounds that have potential applications in pharmaceuticals and biotechnology. She has 1 patent to her name.

Career Highlights

Throughout her career, Su Mi Lee has worked with notable companies in the chemical and pharmaceutical industries. She has been associated with Hanmi Fine Chemical Co., Ltd. and Hanmi Pharm. Co., Ltd., where she has contributed to various research and development projects. Her work has been instrumental in advancing the understanding and application of biocompatible materials.

Collaborations

Su Mi Lee has collaborated with Yeon Jeong Jang, a fellow researcher, to further explore the potential of her inventions. Their partnership has led to significant advancements in their respective fields.

Conclusion

Su Mi Lee's innovative contributions to the field of biochemistry highlight her role as a leading inventor. Her work continues to inspire advancements in the development of bioactive compounds.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…